{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:05:51Z","timestamp":1759017951690,"version":"3.44.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.annder.2014.03.013","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T02:17:18Z","timestamp":1400033838000},"page":"387-391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anticorps de la dermatite herp\u00e9tiforme\u00a0: ce que le dermatologue doit savoir"],"prefix":"10.1016","volume":"141","author":[{"given":"S.","family":"Ingen-Housz-Oro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Amiot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Ortonne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"H\u00fce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2014.03.013_bib0005","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2133.2011.10385.x","article-title":"Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland","volume":"165","author":"Salmi","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2014.03.013_bib0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.annder.2011.01.008","article-title":"Recommandations des centres de r\u00e9f\u00e9rence des maladies bulleuses auto-immunes pour le diagnostic et la prise en charge de la dermatite herp\u00e9tiforme","volume":"138","author":"Ingen-Housz-Oro","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2014.03.013_bib0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.annder.2011.01.005","article-title":"Dermatite herp\u00e9tiforme\u00a0: revue de la litt\u00e9rature","volume":"138","author":"Ingen-Housz-Oro","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2014.03.013_bib0020","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm0797-797","article-title":"Identification of tissue transglutaminase as the autoantigen of celiac disease","volume":"3","author":"Dieterich","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.annder.2014.03.013_bib0025","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20011299","article-title":"Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis","volume":"195","author":"S\u00e1rdy","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.annder.2014.03.013_bib0030","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1096\/fasebj.5.15.1683845","article-title":"Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues","volume":"5","author":"Greenberg","year":"1991","journal-title":"FASEB J"},{"key":"10.1016\/j.annder.2014.03.013_bib0035","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/sj.jid.5701041","article-title":"Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue","volume":"128","author":"Marietta","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2014.03.013_bib0040","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1046\/j.1523-1747.2000.00172.x","article-title":"Concordance of dermatitis herpetiformis and celiac disease in monozygous twins","volume":"115","author":"Hervonen","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2014.03.013_bib0045","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1053\/j.gastro.2005.02.008","article-title":"Overview and pathogenesis of celiac disease","volume":"128","author":"Kagnoff","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annder.2014.03.013_bib0050","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.3748\/wjg.v18.i42.6036","article-title":"Celiac disease: prevalence, diagnosis, pathogenesis and treatment","volume":"18","author":"Gujral","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.annder.2014.03.013_bib0055","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0016-5085(03)01047-3","article-title":"Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease","volume":"125","author":"Mention","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annder.2014.03.013_bib0060","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.immuni.2004.06.018","article-title":"A direct role for NKG2D\/MICA interaction in villous atrophy during celiac disease","volume":"21","author":"H\u00fce","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.annder.2014.03.013_bib0065","doi-asserted-by":"crossref","first-page":"914162","DOI":"10.1155\/2012\/914162","article-title":"Recent advances in dermatitis herpetiformis","volume":"2012","author":"Nakajima","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.annder.2014.03.013_bib0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000234348","article-title":"Detection of antigliadin antibodies in bullous diseases and their recognition of similar antigenic polypeptides","volume":"83","author":"Kumar","year":"1987","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.annder.2014.03.013_bib0075","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1053\/j.gastro.2005.02.028","article-title":"The diagnostic accuracy of serologic tests for celiac disease: a systematic review","volume":"128","author":"Rostom","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annder.2014.03.013_bib0080","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1053\/j.gastro.2005.02.021","article-title":"Should adults be screened for celiac disease? What are the benefits and harms of screening?","volume":"128","author":"Collin","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annder.2014.03.013_bib0085","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1196\/annals.1398.025","article-title":"Diagnostic accuracy of IgA anti-tissue transglutaminase antibody assays in celiac disease patients with selective IgA deficiency","volume":"1109","author":"Villalta","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.annder.2014.03.013_bib0090","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1016\/j.jaad.2005.06.033","article-title":"Dermatitis herpetiformis and partial IgA deficiency","volume":"54","author":"Samolitis","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2014.03.013_bib0095","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/00365520212496","article-title":"Antibodies against human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease","volume":"37","author":"B\u00fcrgin-Wolff","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.annder.2014.03.013_bib0100","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1053\/j.gastro.2005.02.025","article-title":"Follow-up of patients with celiac disease: achieving compliance with treatment","volume":"128","author":"Pietzak","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annder.2014.03.013_bib0105","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1572-0241.2003.07284.x","article-title":"Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease","volume":"98","author":"Vahedi","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.annder.2014.03.013_bib0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1749-6632.1983.tb22220.x","article-title":"IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease","volume":"420","author":"Chorzelski","year":"1983","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.annder.2014.03.013_bib0115","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1373\/clinchem.2009.128132","article-title":"IgG antibodies against deamidated gliadin peptides for diagnosis of celiac disease in patients with IgA deficiency","volume":"56","author":"Villalta","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.annder.2014.03.013_bib0120","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1600-0463.2011.02817.x","article-title":"Immunoglobulin G antibodies against deamidated-gliadin-peptides outperform anti-endomysium and tissue transglutaminase antibodies in children<2years age","volume":"119","author":"Mubarak","year":"2011","journal-title":"APMIS"},{"key":"10.1016\/j.annder.2014.03.013_bib0125","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaad.2011.02.025","article-title":"Novel assay for detecting celiac disease-associated autoantibodies in dermatitis herpetiformis using deamidated gliadin-analogous fusion peptides","volume":"66","author":"Kasperkiewicz","year":"2012","journal-title":"J Am Acad Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963814001276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963814001276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:01:50Z","timestamp":1758970910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963814001276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0151963814001276"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2014.03.013","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticorps de la dermatite herp\u00e9tiforme\u00a0: ce que le dermatologue doit savoir","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2014.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}